Zhao Peng Hu
Director/Board Member chez OCUMENSION THERAPEUTICS
Fortune : 3 M $ au 31/03/2024
Profil
Zhao Peng Hu is currently the Executive Director & Chief Development Officer at Ocumension Therapeutics.
Prior to this, he worked at Santen Pharmaceutical (China) Co. Ltd.
as the Director-Clinical Development & Internal Audit from 2006 to 2018.
Dr. Hu completed his undergraduate degree at Shenyang Pharmaceutical University in 1996.
He then went on to earn his graduate degree from Kyoto Pharmaceutical University in 1999 and his doctorate degree in 2002.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OCUMENSION THERAPEUTICS
0,53% | 05/04/2024 | 3 716 165 ( 0,53% ) | 3 M $ | 31/03/2024 |
Postes actifs de Zhao Peng Hu
| Sociétés | Poste | Début |
|---|---|---|
| OCUMENSION THERAPEUTICS | Director/Board Member | 24/04/2020 |
Anciens postes connus de Zhao Peng Hu
| Sociétés | Poste | Fin |
|---|---|---|
| Santen Pharmaceutical (China) Co. Ltd. | Chief Tech/Sci/R&D Officer | 01/08/2018 |
Formation de Zhao Peng Hu
| Shenyang Pharmaceutical University | Undergraduate Degree |
| Kyoto Pharmaceutical University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OCUMENSION THERAPEUTICS | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Santen Pharmaceutical (China) Co. Ltd. |
